Viewing data from:

FOSCARNET SODIUM

ANDA

FOSCARNET SODIUM | A220068 | CAPLIN STERILES LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: FOSCAVIR(TE code: AP)

API Supply Chain7 active DMFs2 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

TRIFARMA SPAFOSCARNET SODIUM

DMF 190852006

CHEM WERTH INCFOSCARNET SODIUM USP

DMF 289962015

GLAND PHARMA LTDFOSCARNET SODIUM USP

DMF 298142015

EMCURE PHARMACEUTICALS LTDFOSCARNET SODIUM USP

DMF 326522018

BEIJING SCIECURE PHARMACEUTICAL CO LTDFOSCARNET SODIUM

DMF 332882019

MAITHRI DRUGS PRIVATE LTDFOSCARNET SODIUM USP

DMF 349682020

APITORIA PHARMA PRIVATE LTDFOSCARNET SODIUM USP

DMF 350252020

ASTRA CLINICAL RESEARCH ASSOC INCInactiveFOSCARNET SODIUM INTRAVENOUS SOLUTION

DMF 60361985

JIANGSU TIANQING PHARMACEUTICAL FACTORYInactiveFOSCARNET SODIUM

DMF 113851995

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 6GM/250ML (24MG/ML)

0 patents0 exclusivities▴

SOLUTION;INTRAVENOUS | Approved: May 13, 2026

No patent or exclusivity listings for this strength.

Change History (1)

Recent changes detected for this application.

ADDED7/1/2026

Caplin's foscarnet sodium injection (NDA 220068) entered the FDA product database, establishing a new pharmaceutical product record for this antiviral agent.

New: New record